Neal Patterson, Cerner CEO and co-founder, dies from cancer complications

The co-founder and CEO of health IT giant Cerner, Neal Patterson, died July 9 at age 67 according to a company statement.

Patterson’s death was due to “unexpected complications” after a recurrence of the soft-tissue cancer he had previously disclosed publicly in January 2016. Company co-founder Cliff Illig will take over as interim CEO and chairman.

“This is a profound loss. Neal and I have been partners and collaborators for nearly 40 years, and friends for longer than that,” Illig said. “Neal loved waking up every morning at the intersection of healthcare and IT. His entrepreneurial passion for using IT as a lever to eliminate error, variance, delay, waste and friction changed our industry.”

The two founded the company in 1979. When they took it public in 1986, it reported $17 million in revenue. That figure grew to $4.8 billion in 2016, making Cerner one of the dominant firms in health IT with 24,000 employees and the highest market share based on revenue related to electronic health record (EHR) hardware, software and services.

“Neal was a positive role model to me and represented all that is good about Cerner,” Marc Probst, chair of the CHIME Foundation Board and CIO at Intermountain Healthcare in Salt Lake City, Utah, said in a statement. “It was his passion to do what is right for healthcare that allowed Cerner to succeed to the levels it has. I will personally miss his energy, his imagination, his ability to move great ideas forward, his honorable character and the honesty I always felt from him. Neal will be missed by many in the industry.”

Many Kansas City organizations also gave their condolences on Sunday. Cerner is the city’s largest private employer and Patterson’s impact has been felt beyond the business realm, as he was one of five co-owners of Sporting Kansas City, the region’s Major League Soccer franchise.

In its statement, Cerner said its board has a succession plan in place and the process to select a new, permanent CEO “is nearing a conclusion.”

“One of Neal’s enduring ambitions for Cerner was to build a visionary company, not just a company with a visionary,” said Illig. “He has done that. We have what I believe is the best management team in health IT, and we have associates who think as much about the future as they do the present. As a result, Cerner is well-positioned to have a pioneering impact on the provision of healthcare in the years to come.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.